Respiratory Infection Testing Solutions
(CE-IVD & RUO)
Upper Respiratory Panel
Respiratory viruses are a common culprit behind acute infections impacting the upper respiratory tract, including the nose, sinuses, pharynx, and larynx. Furthermore, these viruses can trigger pneumonia, which can be severe and fatal, particularly among vulnerable groups like children, and those with weakened immune systems. Addressing these challenges requires rapid and precise screening methods to manage these conditions effectively and curb transmission.
​
Given the overlapping symptoms caused by various pathogens, diagnosing infectious diseases based solely on symptoms poses difficulties. GeneFirst's syndromic approach is easy to use, allowing clinicians to conduct a comprehensive assessment for a wide array of potential pathogens in a single assay. This method delivers swift and thorough results, empowering clinicians to make informed treatment decisions promptly, ultimately improving patient outcomes and satisfaction.
The GeneFirst Multiplex Probe Amplification (MPA) technology enables real-time PCR detection of multiple targets within a closed-tube reaction. This allows for high throughput testing of patients, supporting accurate and expedited disease management and the prevention of further spread.
Target Pathogen | Strain |
|---|---|
Adenovirus | Types 1, 2, 4, 5, 6 and 7 |
Bocavirus | Type 1 |
Human Coronavirus (HCoV) | Strains 229E, OC43, NL63, and HKU1 |
Human para influenza virus | hPIV1, hPIV2, hPIV3 and hPIV4 (A and B) |
Influenza A | Subtypes H1, H3, H5 and H7 |
Influenza B | Includes Victoria and Yamagata lineages |
Metapneumovirus (MPV) | Subtypes A and B |
Mycoplasma pneumoniae | All known strains |
Respiratory Syncytial Virus (RSV) | Subtypes A and B |
Rhinovirus | Species A, B and C |
Sars-CoV-2 | All known variants of concern |
Catalogue number: RESP003
Kit size: 96 tests
Kit includes: Primers and Probes, Reverse Transcriptase, DNA Polymerase and Positive Control
The GeneFirst Upper Respiratory Panel is CE-IVD marked and is for professional use only.
Lower Respiratory Panel
Testing for lower respiratory diseases, particularly those causing pneumonia, is paramount for comprehensive patient care and public health management. Accurate diagnosis of the causative agent, whether it be bacteria or viruses is essential for guiding appropriate treatment strategies. By identifying the specific pathogen responsible for the infection, healthcare providers can prescribe targeted antimicrobial therapy, minimizing unnecessary antibiotic use and optimizing patient outcomes.
​
Additionally, prompt diagnosis through testing facilitates early initiation of supportive measures, such as supplemental oxygen or respiratory therapies, which are critical for managing severe cases of pneumonia. Beyond individual patient care, testing for lower respiratory diseases plays a crucial role in public health surveillance efforts. Monitoring the prevalence and distribution of pneumonia-causing pathogens allows for timely implementation of infection control measures and targeted vaccination campaigns, helping to prevent outbreaks and reduce the burden of disease on communities.
​
The GeneFirst Multiplex Probe Amplification (MPA) technology enables real-time PCR detection of multiple targets within a closed-tube reaction. This allows for high throughput testing of patients, supporting accurate and expedited disease management and the prevention of further spread.
Target Pathogen | Strain |
|---|---|
Bordetella pertussis | All known strains |
Coxiella burnetii | All known strains |
Haemophilus influenzae | All known strains |
Legionella pneumophila | All known strains |
Moraxella catarrhalis | All known strains |
Mycoplasma pneumoniae | All known strains |
Pneumocystis jirovecii | All known strains |
Staphylococcus aureus | All known strains |
Streptococcus pneumoniae | All known strains |
Catalogue number: RESP005
Kit size: 96 tests
Kit includes: Primers and Probes, Reverse Transcriptase, DNA Polymerase and Positive Control
The GeneFirst Lower Respiratory Panel is CE-IVD marked and is for professional use only.
COVID-19 Testing Solutions
(CE-IVD & RUO)
Throughout the pandemic, GeneFirst Limited have been committed to being a proactive developer and supplier of RT-PCR COVID-19 kits, with the launch of our CE-IVD kits for the detection of SARS-CoV-2 and other commonly circulating viral pathogens. In addition to this, GeneFirst have recently launched a single closed-tube multiplex assay for the detection of currently circulating Variants of Concern, called the COVID-19 Variant Detection Kit.
RT-PCR COVID-19 Detection Kit
Product features
-
In vitro real-time PCR-based test for the detection of two targets (ORF1ab and N gene) of SARS-CoV-2 virus
-
Excellent sensitivity and specificity
-
Single closed-tube assay for ease of use
-
Fast results in under 1 hour 40 minutes
-
Contains appropriate controls for PCR reaction and sample integrity
Catalogue number: COVID-19
Kit size: 96 tests
Kit includes: Primers and Probes, Reverse Transcriptase, DNA Polymerase and Positive Control
The GeneFirst COVID 19 Detection Kit is CE-IVD marked and is for professional use only.
Click here to view the product flyer for more information.
RT-PCR COVID-19 Plus Detection Kit
​Product features
-
In vitro real-time triplex PCR-based test for the detection of SARS-CoV-2, Influenza A/B and Respiratory Syncytial Virus
-
Excellent sensitivity and specificity
-
Single closed-tube assay for ease of use
-
Fast results in under 1 hour 40 minutes
-
Contains appropriate controls for PCR reaction and sample integrity
Catalogue number: RESP002
Kit size: 96 tests
Kit includes: Primers and Probes, Reverse Transcriptase, DNA Polymerase and Positive Control
The GeneFirst COVID-19 Plus Detection Kit is CE-IVD marked for diagnostic use only.
​
Click here to view the product flyer for more information.
RT-PCR COVID-19 Variant Detection Kit
​Product features
​
-
In vitro real-time PCR-based test for the detection of six variants of concern/variants under investigation; B.1.1.7 (Kent), P.1 (Brazil), B.1.351 (South Africa), B.1.525 (Nigeria), B.1.526 (New York) and B.1.1.318
-
Excellent sensitivity and specificity
-
Single closed-tube assay for ease of use
-
Fast results in under 1 hour 20 minutes
-
Contains appropriate controls for PCR reaction and sample integrity
Catalogue number: RESP006
Kit size: 96 tests
Kit includes: Primers and Probes, Reverse Transcriptase, DNA Polymerase and Positive Control
​
The GeneFirst COVID-19 Variant Detection Kit is a Research Use Only assay designed to be used in aiding the triage and stratification of previously confirmed COVID-19 positive samples.
​
Click here to view the product flyer for more information.